Organs-on-Chips Market: A Look at the Industry's Current Status and Future Outlook

The report talks about the shift in demands and emerging trends that are expected to drive the growth of the Organs-on-Chips market. The rising demand for the Organs-on-Chips market is expected to drive the demand for Organs-on-Chips market, thereby bolstering the growth of the industry. Moreover, the report also studies the impact of the COVID-19 pandemic on the market.

The global organ on a chip market size is expected to reach USD 209.4 Million at a steady CAGR of 28.1% in 2028, according to latest analysis by Emergen Research. Steady market revenue growth can be attributed to growing demand for organ on a chip for drug development and screening to reduce monetary losses associated with drug failures. The cost-effectiveness, miniaturized scale, and accurate control of organ on a chip over the mechanical and chemical microenvironment are garnering significant traction across pharmaceutical and biotechnology companies to reduce rate of drug failure. Currently, two-dimensional novel drugs screening and in-vitro pharmacokinetics and pharmacodynamics analysis are prevalent practices before a drug can be sent to the next phase, such as preclinical testing phase. However, human body organs are three-dimensional entities and their intricate behavior cannot be effectively modeled in two-dimensional cultures. Use of organ on a chip provide a microenvironment that mimics the pathophysiological conditions of the human body and thus, helps in saving substantial financial losses by substituting the trial and error method with a more reliable and efficient process.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/617